Image
Image

Polaris by OM1: Clinical Trial Recruitment for Faster, Cost-Effective Trials

On-Demand


OM1-Logo-Blue.jpg


OM1 is pioneering cutting-edge healthcare innovation through its insights-driven technology and data. It specializes in personalized medicine, evidence generation, and real-world evidence (RWE) research powered by next-generation AI platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership.


OM1 is led by a diverse group of scientists, engineers, researchers, and clinicians with over 30 years of experience in RWD/RWE. They have written the handbook on building clinical registries and developing the outcomes measure framework. OM1's unprecedented innovation takes RWE from bench to practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research.

Image
Overview of Webinar:

Clinical trial recruitment remains a major bottleneck for the pharmaceutical industry, with 85% of trials struggling to meet participant targets despite nearly $1.9 billion spent annually. The financial stakes are high, with trial delays, primarily due to patient recruitment costing companies between $600K to $8M per day. Compounding this issue are fragmented healthcare data systems, leaving significant knowledge gaps that slow research and delay patient access to potentially life-saving treatments.

Join us for an insightful webinar on OM1 Polaris, the AI-powered platform that leverages real-world data (RWD) and advanced predictive modeling to optimize clinical trial recruitment. Polaris enables researchers to locate hard-to-find patient populations, particularly for complex conditions like cutaneous lupus, which have low incidence and diagnostic challenges. Learn how this innovative solution accelerates participant identification, streamlines site selection, and reduces recruitment timelines, saving both time and money for pharmaceutical companies.

Learn how OM1 Polaris can accelerate participant identification, streamline site selection, and reduce recruitment timelines for clinical trials, saving time and money.

Featured Topics:

  • Discover how Polaris' AI-driven insights can cut recruitment timelines and reduce trial costs
  • Learn how real-world data and protocol-tailored profiles improve trial outcomes by identifying eligible patients earlier and with greater accuracy.
  • Explore case studies on how Polaris addresses recruitment challenges in rare and underdiagnosed diseases, enhancing trial success and diversity in participant populations.

Speakers:

  • Joseph Zabinski, PhD, MEM
    VP, Head of Commercial Strategy & AI
    OM1
Image
Download the recording

Lorem ipsum dolor sit amet consectetur adipisicing elit. Odit vero harum distinctio autem?

Lorem ipsum dolor sit amet consectetur adipisicing elit. Quam laborum reprehenderit amet in rerum id eum harum qui quos. A est consequatur reprehenderit necessitatibus repudiandae quia harum dolorum praesentium temporibus?

Form Title

Video Title Lorem ipsum dolor sit amet.

Copyright ©